A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells

Upon functional loss of insulin producing islet β-cells, some patients with diabetes become dependent on life-long insulin supplementation therapy. Bioengineering surrogate insulin producing cells is an alternative replacement strategy. We have developed a novel approach using short-activating RNA o...

Full description

Bibliographic Details
Main Authors: Vikash Reebye, Pål Sætrom, Paul J Mintz, John J Rossi, Noriyuki Kasahara, Georgios Nteliopoulos, Joanna Nicholls, Abdelali Haoudi, Myrtle Gordon, Nagy A Habib
Format: Article
Language:English
Published: Elsevier 2013-01-01
Series:Molecular Therapy: Nucleic Acids
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116301561
_version_ 1818137296213377024
author Vikash Reebye
Pål Sætrom
Paul J Mintz
John J Rossi
Noriyuki Kasahara
Georgios Nteliopoulos
Joanna Nicholls
Abdelali Haoudi
Myrtle Gordon
Nagy A Habib
author_facet Vikash Reebye
Pål Sætrom
Paul J Mintz
John J Rossi
Noriyuki Kasahara
Georgios Nteliopoulos
Joanna Nicholls
Abdelali Haoudi
Myrtle Gordon
Nagy A Habib
author_sort Vikash Reebye
collection DOAJ
description Upon functional loss of insulin producing islet β-cells, some patients with diabetes become dependent on life-long insulin supplementation therapy. Bioengineering surrogate insulin producing cells is an alternative replacement strategy. We have developed a novel approach using short-activating RNA oligonucleotides to differentiate adult human CD34+ cells into insulin-secreting cells. By transfecting RNA to increase transcript levels of the master regulator of insulin biosynthesis, v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA), several pancreatic endodermal genes were upregulated during the differentiation procedure. These included Pancreatic and duodenal homeobox gene-1 (PDX1), Neurogenin 3, NeuroD, and NK6 homeobox 1 (NKx6-1). Differentiated CD34+ cells also expressed glucokinase, glucagon-like peptide 1 receptor (GLP1R), sulfonylurea receptor-1 (SUR1) and phogrin'all essential for glucose sensitivity and insulin secretion. The differentiated cells appropriately processed C-peptide and insulin in response to increasing glucose stimulation as shown by enzyme-linked immunosorbent assay (ELISA), fluorescence-activated cell sorting analysis, western blotting, and immunofluorescence staining. We provide a new approach using short-activating RNA in developing insulin producing surrogate cells for treating diabetes.
first_indexed 2024-12-11T09:54:03Z
format Article
id doaj.art-d2178392d1054a4c997cfda696da30bf
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-11T09:54:03Z
publishDate 2013-01-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-d2178392d1054a4c997cfda696da30bf2022-12-22T01:12:19ZengElsevierMolecular Therapy: Nucleic Acids2162-25312013-01-012C10.1038/mtna.2013.23A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ CellsVikash Reebye0Pål Sætrom1Paul J Mintz2John J Rossi3Noriyuki Kasahara4Georgios Nteliopoulos5Joanna Nicholls6Abdelali Haoudi7Myrtle Gordon8Nagy A Habib9Department of Surgery and Cancer, Imperial College London, London, UKDepartment of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, NorwayDepartment of Surgery and Cancer, Imperial College London, London, UKDivision of Molecular Biology, Beckman Research Institute of City of Hope, Duarte, California, USADepartment of Medicine, UCLA School of Medicine, Los Angeles, California, USADepartment of Hematology, Faculty of Medicine, Imperial College London, London, UKDepartment of Surgery and Cancer, Imperial College London, London, UKQatar Biomedical Research Institute, Education City, Doha, QatarDepartment of Hematology, Faculty of Medicine, Imperial College London, London, UKDepartment of Surgery and Cancer, Imperial College London, London, UKUpon functional loss of insulin producing islet β-cells, some patients with diabetes become dependent on life-long insulin supplementation therapy. Bioengineering surrogate insulin producing cells is an alternative replacement strategy. We have developed a novel approach using short-activating RNA oligonucleotides to differentiate adult human CD34+ cells into insulin-secreting cells. By transfecting RNA to increase transcript levels of the master regulator of insulin biosynthesis, v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA), several pancreatic endodermal genes were upregulated during the differentiation procedure. These included Pancreatic and duodenal homeobox gene-1 (PDX1), Neurogenin 3, NeuroD, and NK6 homeobox 1 (NKx6-1). Differentiated CD34+ cells also expressed glucokinase, glucagon-like peptide 1 receptor (GLP1R), sulfonylurea receptor-1 (SUR1) and phogrin'all essential for glucose sensitivity and insulin secretion. The differentiated cells appropriately processed C-peptide and insulin in response to increasing glucose stimulation as shown by enzyme-linked immunosorbent assay (ELISA), fluorescence-activated cell sorting analysis, western blotting, and immunofluorescence staining. We provide a new approach using short-activating RNA in developing insulin producing surrogate cells for treating diabetes.http://www.sciencedirect.com/science/article/pii/S2162253116301561
spellingShingle Vikash Reebye
Pål Sætrom
Paul J Mintz
John J Rossi
Noriyuki Kasahara
Georgios Nteliopoulos
Joanna Nicholls
Abdelali Haoudi
Myrtle Gordon
Nagy A Habib
A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
Molecular Therapy: Nucleic Acids
title A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
title_full A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
title_fullStr A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
title_full_unstemmed A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
title_short A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells
title_sort short activating rna oligonucleotide targeting the islet β cell transcriptional factor mafa in cd34 cells
url http://www.sciencedirect.com/science/article/pii/S2162253116301561
work_keys_str_mv AT vikashreebye ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT palsætrom ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT pauljmintz ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT johnjrossi ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT noriyukikasahara ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT georgiosnteliopoulos ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT joannanicholls ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT abdelalihaoudi ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT myrtlegordon ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT nagyahabib ashortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT vikashreebye shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT palsætrom shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT pauljmintz shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT johnjrossi shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT noriyukikasahara shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT georgiosnteliopoulos shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT joannanicholls shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT abdelalihaoudi shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT myrtlegordon shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells
AT nagyahabib shortactivatingrnaoligonucleotidetargetingtheisletbcelltranscriptionalfactormafaincd34cells